NEURO61

Presentation information

Print

[held on paper]Oral Session

[O-13] Oral Session 13
Neurogenetics / Gene therapy 2 E

[O-13-2] Observational study on nusinersen±cybernic treatment with HAL® for gait function in patients with SMA

○Takashi Nakajima1, Toshio Saito2, Nakabayashi Taiki3, Kazuki Kodera3, Kota Utsumi1, Takeshi Kanayama1, Haruka Urabe1 (1.Department of Neurology, National Hospital Organization Niigata National Hospital, Japan, 2.Department of Neurology, National Hospital Organization Osaka Toneyama Medical Center, 3.Department of Paediatrics, National Hospital Organization Niigata National Hospital)

Abstract password authentication.
Password is written on a pocket program and name badge.

Password